Peter Wipfler

paracelsus medical university

H指数:19

被引数:940

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long-Term Longitudinal Study

抗CD20治疗停药后继发进展型多发性硬化疾病进程——一项多中心长期纵向研究

Annals of Clinical and Translational Neurology

IF3.9

2026-08-200

OAAI

Impact of Anti-CD20 Therapies on Cytokine, Chemokine and Adhesion Molecule Dynamics in Multiple Sclerosis: A Narrative Review

抗CD20疗法对多发性硬化中细胞因子、趋化因子和黏附分子动力学的影响：一篇叙事性综述

Neurology and Therapy

IF4.8

2026-03-130

OAAI

Association of lifestyle and metabolic factors with clinical performance in multiple sclerosis: A cross-sectional study

生活方式和代谢因素与多发性硬化临床表现的关联：一项横断面研究

Medicina Clinica

IF2.1

2026-03-030

OAAI

Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity

选择性S1P受体调节在多发性硬化中改变CXCL13:CXCR5相关的免疫活动，而不影响抗SARS-CoV-2免疫。

Neurology and Therapy

IF4.8

2025-10-080

Long-term impact of oral cladribine on humoral immunity in multiple sclerosis

奥法他滨长期口服治疗对多发性硬化体液免疫的影响

Therapeutic Advances in Neurological Disorders

IF4.1

2025-08-040

Financial burden of out of pocket nonpharmacological therapies in an Austrian multiple sclerosis cohort

奥地利多发性硬化症队列中自用非药物治疗的财务负担

SCIENTIFIC REPORTS

IF3.9

2025-03-190

OAAI

Case report: Reversible splenial lesion syndrome preceding the onset of multiple sclerosis

病例报告: 多发性硬化症发作前的可逆性脾损伤综合征

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-01-070

OAAI

Cerebrospinal Fluid Cytology in Lyme Neuroborreliosis Revisited-Role of Neutrophilic Granulocytes: A Retrospective Single-Center Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-12-050

OAAI

Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery

NEUROLOGY INTERNATIONAL

IF3

2022-11-161

OAAI

The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation

CELLS

IF5.2

2022-08-2524

OAAI

Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities

脑脊液细胞在诊断和研究中的作用和相关性: 最先进的和未充分利用的机会

DIAGNOSTICS

IF3.3

2021-12-307

OAAI

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy

BIOMEDICINES

IF3.9

2021-10-317

OAAI

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study

MULTIPLE SCLEROSIS JOURNAL

IF5

2021-10-0117

OAAI

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF

FLUIDS AND BARRIERS OF THE CNS

IF6.2

2021-08-2618

OAAI

Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-08-265

OAAI

Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction

血清，CSF和血CSF屏障功能中的趋化因子CXCL13: 隔室限制的证据

FLUIDS AND BARRIERS OF THE CNS

IF6.2

2020-02-2423

OAAI

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study

JOURNAL OF NEUROINFLAMMATION

IF10.1

2019-01-1913

OAAI

Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration

JOURNAL OF VIROLOGY

IF3.8

2017-06-0119

OAAI

High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis

多发性硬化症患者脑脊液中CD4/CD8 T细胞比率和那他珠单抗浓度水平的高个体间差异

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2015-04-2720

OAAI

Tumefactive MS lesions under fingolimod A case report and literature review

NEUROLOGY

IF8.5

2013-11-0561

PREAI

Peter Wipfler

个人简介

教育背景

工作经历

荣誉奖项

研究方向